Advancing global equity in liver disease research funding: the case of metabolic dysfunction-associated and alcohol-associated liver disease

Key Points

• This research aims to explore the disparities in liver disease research funding and advocate for improved global equity.
• Analysis of global liver disease mortality data
• Comparison of funding levels across different liver disease types
• Examination of resource allocation trends
• Over 2 million deaths from liver disease annually
• Significant funding gaps identified for metabolic dysfunction-associated liver diseases
• Call for increased investment in underfunded liver disease areas